கிருஷன் எல்லா பாரத் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கிருஷன் எல்லா பாரத். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கிருஷன் எல்லா பாரத் Today - Breaking & Trending Today

What Is Bharat Biotech's Nasal Vaccine For Coronavirus? Deets Inside

What Is Bharat Biotech s Nasal Vaccine For Coronavirus? Deets Inside
Mar 05, 2021, 15:28 IST
Dr Krishan Ella s Bharat Biotech has started the process of screening potential clinical trial participants at four centres in India - Nagpur, Hyderabad, Patna and Chennai for their new nasal vaccine against Covid19.
As per Bharat Biotech s website, An intranasal vaccine stimulates a broad immune response neutralising IgG, mucosal IgA, and T cell responses and creates an immune response at the site of infection (in the nasal mucosa) essential for blocking both infection and transmission of Covid-19.
What are the benefits of having an intranasal vaccine
Cost-effective
It will be cheaper and cost-effective and there would be ease of administration with no injections, says Dr Sanjeev Bagai, an avid vaccine watcher and chairman at the Nephron Clinic in Delhi. Bharat Biotech has said that the scalability to manufacture this would help meet the global demand. ....

Andhra Pradesh , Tamil Nadu , Giridhara Babu , Sanjeev Bagai , Krishan Ella Bharat , Bharat Biotech , Nephron Clinic , Professor Giridhara , Nasal Vaccine , Covid 19 Nasal Vaccine , Bharat Biotech Nasal Vaccine , Clinical Trials On Bharat Biotech , Bbv154 Intranasal Vaccine Bharat Biotech , Bharat Biotech International Limited , Corona Virus , Covid 19 Vaccine , ஆந்திரா பிரதேஷ் , தமிழ் நாடு , சஞ்சீவ் பாகாய் , கிருஷன் எல்லா பாரத் , பாரத் பயோடெக் , நெஃப்ரான் சிகிச்சையகம் , நாசி தடுப்பூசி , பாரத் பயோடெக் நாசி தடுப்பூசி , மருத்துவ சோதனைகள் ஆன் பாரத் பயோடெக் , பாரத் பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை ,

Bharat Biotech's nasal vaccine for Covid-19 likely to be a game-changer. Here's why

Bharat Biotech s nasal vaccine for Covid-19 likely to be a game-changer. Here s why
Bharat Biotech s nasal vaccine for Covid-19 likely to be a game-changer. Here s why
If approved after clinical trials, the nasal vaccine developed by Bharat Biotech could prove to be a game-changer. Sneha Mordani explains why.
advertisement
UPDATED: March 5, 2021 01:00 IST
Bharat Biotech is set to start phase 1 of clinical trials for its nasal vaccine soon | Representative image from AFP
In the summer of the year 2020, the chairman and managing director of India’s premier vaccine developing company, Bharat Biotech International Limited told the reporter that while efforts were on to develop an intramuscular vaccine against Covid-19, what he really would want to do is develop a vaccine that will be easy to administer like ‘polio drops’. ....

Andhra Pradesh , Tamil Nadu , Harsh Vardhan , Giridhara Babu , Sanjeev Bagai , Krishan Ella Bharat , Bharat Biotech International , Bharat Biotech International Limited , Krishan Ella , Bharat Biotech , Nephron Clinic , Professor Giridhara , Nasal Vaccine , Covid 19 Nasal Vaccine , Nasal Vaccine Clinical Trial , ஆந்திரா பிரதேஷ் , தமிழ் நாடு , கடுமையான வர்தன் , சஞ்சீவ் பாகாய் , கிருஷன் எல்லா பாரத் , பாரத் பயோடெக் சர்வதேச , பாரத் பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை , கிருஷன் எல்லா , பாரத் பயோடெக் , நெஃப்ரான் சிகிச்சையகம் , நாசி தடுப்பூசி ,